Status:
UNKNOWN
Outcome of Esmolol Potassium Cardioplegia Compared to Potassium Cardioplegia in Patients With Solitary Valvular Disease; Randomized Controlled Study
Lead Sponsor:
Kasr El Aini Hospital
Conditions:
Cardioplegia Solution Adverse Reaction
Eligibility:
All Genders
20-50 years
Phase:
NA
Brief Summary
Perioperative myocardial injury remains one of the most serious complications of cardiac surgery. Numerous factors have been implicated during the pathogenesis process, including the technique of car...
Eligibility Criteria
Inclusion
- \- 20-50 years old patients, with either sex with solitary valvular disease
Exclusion
- • Myocardial infarction within 2 weeks.
- History of reaction or toxicity to esmolol or other beta blockers.
- New York Heart Association class IV congestive heart failure despite treatment.
- Persistent hypotension (systolic blood pressure \<80 mm Hg).
- severe pulmonary hypertension
- Ejection fraction less than 45%
- Patients with coronary artery disease
- Patients with congenital heart disease
- Patients with previous cardiac surgery
- Patients with liver disease (child class B and C)
- Patients with second or third degree heart block
- Patients having resting heart rate less than 50 ppm
- Patients using calcium channel blockers
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04306913
Start Date
April 1 2020
End Date
September 1 2020
Last Update
March 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr alainy medical school
Cairo, Egypt, 12566